A randomized controlled efficacy trial of behavioral activation for concurrent stimulant use and sexual risk for HIV acquisition among MSM: project IMPACT study protocol
Open Access
- 25 July 2018
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 18 (1) , 1-11
Abstract
In the United States, problematic stimulant use is a prevalent and difficult to treat problem among men who have sex with men (MSM), as well as a major driver of HIV transmission through the large number of sexual partners and concomitant condomless anal sex (CAS). Evidence-based behavioral studies that address problematic stimulant use in MSM at risk for HIV infection are also lacking. In this paper, we describe the design of a behavioral intervention trial to reduce sexual risk behavior and stimulant use in HIV-uninfected MSM. This study, funded by the National Institute on Drug Abuse (NIDA), is a randomized controlled trial (RCT) testing an integrated HIV risk reduction and behavioral activation counseling intervention (IMPACT) for HIV-uninfected, stimulant using MSM in Boston, MA, and Miami, FL. Participants are randomized (2:2:1) to either (1) the IMPACT intervention; (2) a relaxation condition, an active therapy time- and intensity-matched control; or (3) a standard of care risk reduction counseling comparison. At enrollment, all participants receive an HIV test and pre- and post-test counseling. The primary outcome is the difference in the rate of change in the number of self-reported condomless anal sex acts without the protection of consistent Pre-Exposure Prophylaxis (PrEP) use, as well as reductions in stimulant use during the prior 4-months. Major assessments are conducted at baseline, 4-, 8-, and 12-month follow-up visits. Effective and sustainable behavioral interventions are sorely needed to reduce HIV acquisition in stimulant using MSM at risk for HIV infection. In this study, we will evaluate the evidence of efficacy of the IMPACT intervention to reduce HIV acquisition in HIV-uninfected, stimulant-using MSM. If found effective, the intervention tested here holds promise for being readily integrated into real-world clinical settings. ClinicalTrials.gov number NCT03175159 , registered June 5, 2017.Keywords
Funding Information
- National Institute on Drug Abuse (R01DA042805)
This publication has 74 references indexed in Scilit:
- Development of the Perceived Risk of HIV ScaleAIDS and Behavior, 2011
- Cognitive Behavioral Therapy vs Relaxation With Educational Support for Medication-Treated Adults With ADHD and Persistent SymptomsJAMA, 2010
- Crystal Methamphetamine Use and Sexual Risk Behaviors among HIV-Positive and HIV-Negative Men Who Have Sex with Men in South FloridaJournal of Urban Health, 2010
- Randomized trial to reduce club drug use and HIV risk behaviors among men who have sex with men.Journal of Consulting and Clinical Psychology, 2009
- Experiences and Sexual Behaviors of HIV–Infected MSM Who Acquired HIV in the Context of Crystal Methamphetamine UseAIDS Education and Prevention, 2008
- The Relationship Between Methamphetamine and Popper Use and Risk of HIV Seroconversion in the Multicenter AIDS Cohort StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2007
- Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependenceDrug and Alcohol Dependence, 2006
- HIV-Associated Medical, Behavioral, and Psychiatric Characteristics of Treatment-Seeking, Methamphetamine-Dependent Men Who Have Sex with MenJournal of Addictive Diseases, 2005
- Reliability and validity of the Hamilton Depression Inventory: A paper-and-pencil version of the Hamilton Depression Rating Scale Clinical Interview.Psychological Assessment, 1995
- Changing AIDS-risk behavior.Psychological Bulletin, 1992